No Evidence That Glatiramer Acetate Slows Multiple Sclerosis (MS) Progression
London, Ontario, November 1 (ots/PRNewswire) - In this week's issue of the Lancet Neurology, glatiramer acetate, known as Copaxone(R), was subjected to an independent review. The systematic review, called a Cochrane Review, performed by Dr. Luca Munari and colleagues, challenges the claims of benefit from previous industry-based publications. A convincing ...
mehr